Rocket


Overview
Financials
News + Filings

 
 

Ayala Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues-0.20.0
Cost of goods sold-1.30.0
Gross profit1.00.0
            Gross margin-444.5% 
Research and development14.45.7
General and administrative4.33.3
EBIT-17.7-9.0
            EBIT margin7504.7% 
Pre-tax income-17.5-8.6
Income taxes0.30.3
Net income-17.8-8.9
            Net margin7539.0% 
 
Diluted EPS($1.79)($0.90)
Shares outstanding (diluted)10.09.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy